Innate immunity in diabetic kidney disease

Area of Science:

• Nephrology
• Immunology
• Endocrinology

Background:

• Renal inflammation is increasingly recognized as a key factor in diabetic kidney disease (DKD) pathogenesis and progression.
• Innate immune cells and resident renal cells play critical roles in initiating and maintaining inflammation in DKD.
• Several innate immune pathways are implicated in the development and worsening of DKD.

Purpose of the Study:

• To review the roles of innate immune pathways in the pathogenesis of diabetic kidney disease.
• To explore the potential of targeting these pathways for renoprotective therapies in DKD.

Main Methods:

• Review of clinical and experimental studies.
• Analysis of innate immune pathways involved in DKD, including Toll-like receptors, NLRP3 inflammasome, kallikrein-kinin system, protease-activated receptors, and complement cascade.
• Examination of mechanisms linking hyperglycemia to inflammation and fibrosis.

Main Results:

• Toll-like receptors detect danger signals in diabetes, activating NF-κB and causing tubulointerstitial inflammation.
• The NLRP3 inflammasome links metabolic stress to inflammation via IL-1β and IL-18.
• Kallikrein-kinin system and protease-activated receptors contribute to inflammation and fibrosis.
• Hyperglycemia-induced protein glycation activates the complement cascade.

Conclusions:

• Innate immune pathways are central to DKD pathogenesis.
• Targeting these pathways, such as Toll-like receptors and NLRP3 inflammasome, shows promise for novel renoprotective strategies in DKD.
• Preclinical data support the development of anti-inflammatory therapies for DKD.